Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NS-065/NCNP-01 in Duchenne Muscular Dystrophy
NCT02081625Phase 1Completed
- Sponsor
- National Center of Neurology and Psychiatry
- Start
- Jun 2013
- Primary completion
- Nov 2014
- Countries
- 1
01
Overview
Phase 1, open-label trial of viltolarsen in Duchenne muscular dystrophy (DMD), sponsored by National Center of Neurology and Psychiatry. Started Jun 2013; status: completed.
02
Drugs
viltolarsen
03
Conditions
Duchenne muscular dystrophy (DMD)
Beyond the preview
Go deeper on NCT02081625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02081625.